Bionano Genomics (BNGO) Equity Ratio (2017 - 2025)
Historic Equity Ratio for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to 0.63.
- Bionano Genomics' Equity Ratio rose 1261.24% to 0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63, marking a year-over-year increase of 1261.24%. This contributed to the annual value of 0.46 for FY2024, which is 287.81% up from last year.
- Latest data reveals that Bionano Genomics reported Equity Ratio of 0.63 as of Q3 2025, which was up 1261.24% from 0.6 recorded in Q2 2025.
- In the past 5 years, Bionano Genomics' Equity Ratio ranged from a high of 0.97 in Q2 2021 and a low of 0.45 during Q4 2023
- Its 5-year average for Equity Ratio is 0.73, with a median of 0.79 in 2023.
- In the last 5 years, Bionano Genomics' Equity Ratio skyrocketed by 52731.94% in 2021 and then tumbled by 4470.28% in 2023.
- Over the past 5 years, Bionano Genomics' Equity Ratio (Quarter) stood at 0.89 in 2021, then decreased by 9.28% to 0.81 in 2022, then plummeted by 44.7% to 0.45 in 2023, then grew by 2.88% to 0.46 in 2024, then soared by 36.52% to 0.63 in 2025.
- Its Equity Ratio was 0.63 in Q3 2025, compared to 0.6 in Q2 2025 and 0.61 in Q1 2025.